Afatinib, sold under the brand name Gilotrif among others, is a medication which is used to treat non-small cell lung carcinoma (NSCLC). It belongs to...
15 KB (1,122 words) - 15:16, 4 August 2024
Quinazoline (section Afatinib)
approved afatinib, a drug developed by Boehringer Ingelheim, as an irreversible, competitive inhibitor of HER2 and EGFR kinases. While afatinib demonstrates...
14 KB (1,240 words) - 01:14, 27 July 2024
sofosbuvir/daclatasvir, osimertinib, crizotinib, daclatasvir, sofosbuvir, afatinib, axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib...
5 KB (232 words) - 10:23, 8 March 2024
Angiokinase inhibitors (section BIBW 2992 (afatinib))
targeting receptor tyrosine kinases. Examples include nintedanib (BIBF 1120), afatinib (BIBW 2992) and motesanib (AMG 706). The term angiokinase was first documented...
12 KB (1,445 words) - 03:23, 5 December 2023
other EGFR tyrosine kinase inhibitors, such as gefitinib, erlotinib, and afatinib. In the US, EGFR exon 19 deletions, exon 21 L858R mutations or the T790M...
17 KB (1,489 words) - 05:47, 7 April 2024
(INN) afalanine (INN) afamelanotide (INN) afamitresgene autoleucel (INN) afatinib (INN, (USAN) Afaxin afegostat (USAN, INN) afelimomab (INN) afimoxifene...
5 KB (341 words) - 03:58, 5 August 2024
Nepidermin Transforming growth factor alpha (TGFα) Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin...
31 KB (3,430 words) - 05:24, 28 August 2024
Nepidermin Transforming growth factor alpha (TGFα) Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin...
68 KB (5,999 words) - 20:41, 31 August 2024
Nepidermin Transforming growth factor alpha (TGFα) Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin...
121 KB (13,799 words) - 18:32, 22 August 2024
Nepidermin Transforming growth factor alpha (TGFα) Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin...
92 KB (8,671 words) - 18:15, 17 August 2024